Ledger.Open graph →
SEC Form D · filed March 12, 2025

Antares Therapeutics, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Adam Friedman · Boston, MAExec · DirectorAndrew Fedder · Boston, MAExec · DirectorBrian Piper · Boston, MAExec · DirectorAndrew Fedder · Boston, MAExec · DirectorAdam Friedman · Boston, MAExec · DirectorBrian Piper · Boston, MAExec · DirectorHiroaki Kobayashi · BALTIMORE, MDExec · DirectorJeffrey Cleland · BALTIMORE, MDExec · DirectorAkihiro Ko · BALTIMORE, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗